Source launches first ETF in Europe of Nasdaq biotechnologies index


p { margin-bottom: 0.1in; line-height: 120%; } The investment company and ETP provider Source on 10 November announced the launch of the Source NASDAQ Biotechnology UCITS ETF, the first ETF to be listed in Europe to aim to replicate the NASDAQ Biotechnology index. The NASDAQ Biotechnology UCITS ETF is denominated in USD, and trades on the London Stock Exchange. It is also licensed for sale in Germany, Austria, Finland, France, Ireland, Italy (reserved for institutional invetors), Luxembourg, the Netherlands, Norway (reserved for institutional investors), Switzerland (reserved for institutional investors) and Sweden.